Samsung Medical Center Study Warns of 'Shortcut Learning' in AI Diagnostics

Researchers at Samsung Medical Center have uncovered a critical flaw in the application of machine learning to diagnose pheochromocytomas and paragangliomas (PPGL), warning that AI can mistake administrative patterns for medical evidence. The findings, presented at the Association for Diagnostics & Laboratory Medicine (ADLM) 2026 Annual Scientific Meeting in Anaheim, California, highlight the risk of "shortcut learning" in clinical settings.

The study analyzed data from 20,516 adults who underwent plasma-free metanephrine testing at Samsung Medical Center between 2011 and 2024. While initial machine learning models appeared to significantly boost diagnostic performance by integrating clinical data, further analysis revealed these gains were illusory. The models were not identifying independent biochemical signals of the disease; instead, they were relying on "informative missingness," identifying patterns of follow-up tests that clinicians had already ordered because they suspected the patient had the condition.

The Challenge of False Positives

Plasma-free metanephrines serve as the first-line test for PPGL, which are rare tumors located near the adrenal glands. Although the test is highly sensitive, it is prone to producing false positives. According to the study, among 19,797 patients who did not have PPGL, 25.2% exhibited metanephrine elevations that could have triggered a false-positive result. This high rate of mild elevation in healthy patients creates a pressing need for more precise discrimination tools to avoid unnecessary patient anxiety and invasive procedures.

The Danger of AI Shortcuts

This research serves as a cautionary tale for the broader integration of artificial intelligence in healthcare. It demonstrates that high performance metrics in a laboratory or retrospective setting can be misleading if a model picks up on behavioral proxies—such as how a doctor manages a patient—rather than actual biological markers. When a model learns that the presence of a specific follow-up test is a predictor of disease, it is not diagnosing the patient; it is diagnosing the clinician's suspicion.

"The key message is not that machine learning cannot help, but that routine-care models must be audited to confirm they are learning the intended clinical signal," said Se-eun Koo, a clinical chemistry fellow at Samsung Medical Center.

Ensuring Clinical Safety

To prevent the introduction of biases or errors into active clinical practice, the researchers emphasize that ML models must undergo rigorous auditing for shortcut learning and extensive external validation. The study concludes that for AI to function as a safe diagnostic aid, it must be proven to rely on the intended physiological data rather than the administrative footprints of the healthcare system.